Human Identification Market Overview
The need for human identification is expected to grow at a compound annual growth rate (CAGR) of 8.89% worldwide. By 2033, the market's revenue is expected to have grown to USD 6.59 billion from its estimated USD 2.79 billion in 2023.
To help end users resolve difficult cases and give investigative leads in a forensically responsible manner, key companies offer streamlined, end-to-end forensic DNA analysis procedures. The market is expanding steadily because of their commitment to offering unmatched service and constant innovation to meet the needs of both the present and the future. The success of subsequent analyses is directly related to the quantity and caliber of genomic DNA that is extracted and purified from a forensic material. The Precision ID NGS System for HID can help end users solve challenging issues by obtaining more information from challenging samples.
Their goal of offering forensic DNA testing in their community sooner is being aided by the prompt installation of a brand-new, state-of-the-art forensic scientific services facility. They were able to start processing DNA evidence thanks to the assistance of Life Technologies application specialists, who helped expedite the process and enhance validation quality assurance. It is anticipated that this invention will quicken market expansion. With substantially higher resolution than was previously possible, several key players' next-generation sequencing (NGS) technology and informatics provide forensic DNA with a lot more information than conventional PCR and capillary electrophoresis (CE) techniques. Key firms assert that their customers may be able to get the answers they require more quickly and with greater confidence because to the targeted strength of NGS-based forensic genomics approaches, which will increase the industry.
Labs have a complete, fast solution with the three-step human whole-genome sequencing approach. High-quality insights for every variant class across the entire genome are provided by the resulting WGS. Due to rising time and resource demands, forensics and human identification labs are constantly under pressure to optimize operational efficiency without sacrificing quality. The market is anticipated to benefit from the rise in demand. For more than 20 years, a few respectable, noteworthy companies have served as reliable partners and suppliers of solutions to forensics labs around the world. Whether they operate in a high-throughput facility or a small lab, they have developed a whole suite of solutions that provide end users with the speed, accuracy, and reliability they desire. Their state-of-the-art services and solutions could benefit end users across the entire human identification process. The market is anticipated to expand further given the measures already in place by major companies and the advancements made in human identification.
By supporting forensic scientists at every level of their careers, they strive to further the field of forensics through their Investigator Community activities. FISH is a useful technique for identifying different chromosomal abnormalities. Among the DNA FISH probes available for preimplantation, prenatal, and postnatal genetic testing investigations is AneuVysion, the only FDA-approved instrument for the quick identification of anatomy in amniotic fluid samples. When getting ready to testify in court, a trustworthy STR profile is essential. Important businesses offer a wide range of multiplex PCR kits for paternity and human identification testing, giving end customers assurance in their proof. These STR kits offer the most comprehensive and flexible coverage of current international STR requirements for casework and reference materials, with high levels of sensitivity and durability.
Important businesses provide thorough, coordinated, and effective processes for forensic testing and all forms of human identification (human ID). End users can begin with their new sample collection portfolio and then speed up their process with a variety of automated sample purifying options.
Market Drivers:
Increasing Demand for DNA Analysis
The increase in demand for DNA analysis will cushion the growth rate of human identification market. Along with this, enhancing demand for reducing the time as well as cost of DNA analysis will cushion the 'market's growth rate during the forecast period.
Rising Number of Government Initiatives for Forensic Programs
The growing number of government initiatives for forensic programs is driving the global market for human identification. Given the potential, demand, and uses of human identification across a wide range of industries, governments worldwide have stepped up their support for the market's growth.
Additionally, one of the main factors driving the expansion of the human identification market will be the increase in criminal instances. In addition, the pharmaceutical and biotechnology sectors' technological advancements and growing urbanization are the main drivers propelling the market for human identification. Additionally, the primary key factors that would accelerate the growth of the human identity market are the rise in changing lifestyles and rising healthcare infrastructure spending. The rising use of real-time analytics to follow the digital transformation is a critical component of the human identification market's growth, as are the latest technological advancements in human identification and the processing of large amounts of data.
Market Opportunities:
Growing Number of Application of Human Identification
Moreover, the use of human identification in fields including human trafficking prevention, criminal investigations, and medicine will create new growth potential in the global industry during the forecast period.
Emerging Markets
Emerging markets are likely to provide considerable growth possibilities for market competitors in the future years. Several Asian governments have also pledged their support for the development of human identification products and forensic research.
Market Restraints:
High cost Associated with the Genomic Instruments
However, the high cost associated with the genomic instruments will impede the growth rate of the human identification market.
The Dearth of Finances
Lack of funding for additional developments in the human identification industry is anticipated to hinder the market's expansion. Technological developments need a large expenditure in research and development, which raises service costs.
However, the market for human identification will be hampered by the lack of qualified workers in developing countries. Furthermore, during the projection period of 2023–2033, the COVID-19 outbreak and the lack of awareness in developing nations would create adverse conditions that will act as a restraint and further hamper the market's growth rate.
Trade regulations, import-export analysis, production analysis, value chain optimization, market share, prospects for emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, and technological innovations in the market are all covered in detail in this report on the human identification market. Contact Data Bridge Market Research for an Analyst Brief to learn more about the human identification market. Our staff can assist you in making well-informed decisions to achieve market expansion.
Segmentation Analysis:
By Product Type Analysis:
Depending on the product, the human identification market is divided into three categories: consumables, instruments, and software. The consumables segment became the market's top sector in 2023. Consumables like DNA extraction kits, fingerprinting supplies, and reagents are essential parts of routine identification processes, and their widespread and bulk purchases, as well as the introduction of numerous new and sophisticated consumables by market participants in recent years, are largely responsible for this segment's high share.
By End User Analysis:
The market for human identification is divided into several end users, such as forensic labs, research facilities, academic and governmental institutions, and others. The forensic laboratories segment held the highest share of the market as of 2023. The main reason for this dominance is because forensic labs usually deal with a lot of cases and samples, particularly in places with high crime rates or populations. In addition to performing forensic biological, toxicological, and controlled substance identification testing, forensic laboratories also examine criminal evidence.
By Region Analysis:
The market for human identification is dominated by North America due to the growing number of research and development initiatives by different life science businesses in this area. Furthermore, the market's growth rate in this area would be boosted by the existence of significant key players.
Due to the rising amount of money being spent on the development of healthcare infrastructure in this region, Asia-Pacific is anticipated to expand throughout the forecast period. Additionally, the market's growth rate in this region would be accelerated by growing awareness of human identification technology.
The report's nation section additionally lists specific market-influencing factors and domestic regulatory changes that affect the market's present and future developments. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Key Companies:
Thermo Fisher Scientific Inc.
Illumina Inc.
Agilent Technologies Inc.
QIAGEN
Bio-Rad Laboratories Inc.
Hamilton Company
Ande Corporation
Abbott Laboratories
GE Healthcare
Eurofins Scientific
Laboratory Corporation of America Holdings
Industry Developments:
In June 2023, QIAGEN N.V. (Netherlands) announced the US FBI approval of its ForenSeq MainstAY workflow, enabling accredited forensic DNA labs to analyze DNA casework samples and cross-reference profiles with the US.
In March 2023, InnoGenomics Technologies, LLC (US) announced a nanotechnology-based approach called SpermX, significantly enhancing the yield of usable results.
In January 2023, Promega Corporation’s (US) launch of the PowerPlex 35GY System introduces a novel DNA analysis chemistry, empowering forensic labs to use degraded and contaminated samples.
In January 2023, QIAGEN N.V. (Netherlands) finalized the acquisition of Verogen (US), a frontrunner in leveraging NGS technologies in human identification (HID) and forensic applications..
In January 2022, a research team led by Stanford University set the first Guinness World Record for the quickest DNA sequencing technology, which was utilized to sequence the human genome in 5 hours and 2 minutes.
In June 2021, Precision ID GlobalFiler NGS STR Panel v2 for forensic DNA analysis has been released by Thermo Fisher Scientific. The capability of the Applied Biosystems Precision ID GlobalFiler NGS STR Panel v2 is combined with that of the Converge Software 2.0 solution in this next-generation sequencing STR panel.
In June 2021, QIAGEN N.V. had announced a commercialization partnership with San Diego-based human identification specialist Verogen. Customers of both firms will benefit from enhanced tools and full support for human identification (HID) workflows in their laboratories as a result of this collaboration.
In 2021, QIAGEN introduced the EZ2 Connect Instrument Line, which may accelerate the advancement of biological research, forensics, and clinical diagnostics.
Report Segmentations:
By Product Type
Instruments
Software & Data Management
Assay Kits & Cartridges
By Technology
Polymerase Chain Reaction (PCR)
Short Tandem Repeats (STR)
Microarray Technology
Capillary Electrophoresis
Next Generation Sequencing (NGS)
Nucleic Acid Extraction & Purification
Rapid DNA Analysis
By Application
Molecular Forensic Analysis
DNA Database Updating
Paternity & Kinship Testing
Crime & Sexual Assault Investigation
Missing Person Investigation
Disaster Victim Identification
Anthropology Studies
Cell Line Identification
Population-based Studies
Genetic-based Studies
By End User
Forensic Laboratories
Law Enforcement Agencies
Academic & Research Labs
Pharmaceutical & Biotech Companies
Contract Research Organizations
By Region
North America
Europe
Asia Pacific
South America
Middle East and Africa
Report Attribute | Details |
Market size value in 2023 | USD 2.79 billion |
Revenue forecast in 2033 | USD 6.59 billion |
Growth rate | CAGR of 8.89% from 2023 to 2033 |
Base year for estimation | 2023 |
Historical data | 2018 - 2022 |
Forecast period | 2023 - 2033 |
Quantitative units | Revenue in USD million and CAGR from 2023 to 2033 |
Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered | By Product Type, By Technology, By Application, By End User |
Regional scope | North America, Europe, Asia Pacific, Latin America, MEA |
Country scope | U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Denmark, Norway, Sweden, China, Japan, India, Australia, South Korea, Thailand, Brazil, Argentina, South Africa, Saudi Arabia, UAE, Kuwait |
Key companies profiled | Thermo Fisher Scientific Inc., Illumina Inc., Agilent Technologies Inc., QIAGEN, Bio-Rad Laboratories Inc., Hamilton Company, Ande Corporation, Abbott Laboratories, GE Healthcare, Eurofins Scientific, Laboratory Corporation of America Holdings |
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te